Parzych SE - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance.

Davis LN, Walker ZJ, Reiman LT, Parzych SE, Stevens BM, Jordan CT, Forsberg PA, Sherbenou DW. Davis LN, et al. Among authors: parzych se. Clin Cancer Res. 2024 Jul 15;30(14):3023-3035. doi: 10.1158/1078-0432.CCR-24-0256. Clin Cancer Res. 2024. PMID: 38723281 Free PMC article.

Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies.

Keller AL, Reiman LT, Perez de Acha O, Parzych SE, Forsberg PA, Kim PS, Bisht K, Wang H, van de Velde H, Sherbenou DW. Keller AL, et al. Among authors: parzych se. Cancer Res Commun. 2024 Mar 12;4(3):757-764. doi: 10.1158/2767-9764.CRC-23-0434. Cancer Res Commun. 2024. PMID: 38421887 Free PMC article.

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies.

Perez de Acha O, Reiman L, Jayabalan DS, Walker ZJ, Bosma G, Keller AL, Parzych SE, Abbott D, Idler BM, Ribadeneyra D, Niesvizky R, Forsberg PA, Mark TM, Sherbenou DW. Perez de Acha O, et al. Among authors: parzych se. Blood Adv. 2023 Nov 14;7(21):6430-6440. doi: 10.1182/bloodadvances.2023010162. Blood Adv. 2023. PMID: 37648670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters